[Surgical results and indications for adjuvant measures in pancreatic cancer].
Beger
H G
HG
Chirurgische Klinik I, Universitätsklinikum Ulm.
Büchler
M W
MW
Friess
H
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D016577:Pancreaticoduodenectomy; D011879:Radiotherapy Dosage; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D006728:Hormones
Chirurgische Ergebnisse und Indikation zu adjuvanten Massnahmen beim Pankreascarcinom.